nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—urinary bladder cancer	0.495	1	CbGaD
Benazepril—MTHFR—Fluorouracil—urinary bladder cancer	0.234	0.645	CbGbCtD
Benazepril—MTHFR—Methotrexate—urinary bladder cancer	0.129	0.355	CbGbCtD
Benazepril—ACE—umbilical vein—urinary bladder cancer	0.0058	0.161	CbGeAlD
Benazepril—ACE—urine—urinary bladder cancer	0.00468	0.13	CbGeAlD
Benazepril—MTHFR—Metabolism of folate and pterines—SLC19A1—urinary bladder cancer	0.00453	0.212	CbGpPWpGaD
Benazepril—MTHFR—prostate gland—urinary bladder cancer	0.00275	0.0764	CbGeAlD
Benazepril—SLC15A1—epithelium—urinary bladder cancer	0.00172	0.0478	CbGeAlD
Benazepril—ACE—prostate gland—urinary bladder cancer	0.00168	0.0467	CbGeAlD
Benazepril—SLC15A1—renal system—urinary bladder cancer	0.0016	0.0444	CbGeAlD
Benazepril—MTHFR—female reproductive system—urinary bladder cancer	0.0015	0.0417	CbGeAlD
Benazepril—SLC15A2—prostate gland—urinary bladder cancer	0.00147	0.0407	CbGeAlD
Benazepril—ACE—seminal vesicle—urinary bladder cancer	0.00142	0.0395	CbGeAlD
Benazepril—MTHFR—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00125	0.0584	CbGpPWpGaD
Benazepril—SLC15A2—seminal vesicle—urinary bladder cancer	0.00124	0.0344	CbGeAlD
Benazepril—ACE—epithelium—urinary bladder cancer	0.00123	0.0343	CbGeAlD
Benazepril—ACE—smooth muscle tissue—urinary bladder cancer	0.00119	0.033	CbGeAlD
Benazepril—SLC15A1—vagina—urinary bladder cancer	0.00116	0.0321	CbGeAlD
Benazepril—ACE—renal system—urinary bladder cancer	0.00115	0.0318	CbGeAlD
Benazepril—ACE—urethra—urinary bladder cancer	0.00113	0.0312	CbGeAlD
Benazepril—SLC15A2—renal system—urinary bladder cancer	0.000999	0.0277	CbGeAlD
Benazepril—SLC15A2—urethra—urinary bladder cancer	0.000981	0.0272	CbGeAlD
Benazepril—MTHFR—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000975	0.0456	CbGpPWpGaD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.00095	0.0444	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000921	0.0431	CbGpPWpGaD
Benazepril—ACE—female reproductive system—urinary bladder cancer	0.000917	0.0255	CbGeAlD
Benazepril—MTHFR—lymph node—urinary bladder cancer	0.000879	0.0244	CbGeAlD
Benazepril—ACE—Peptide hormone metabolism—CDX2—urinary bladder cancer	0.000819	0.0383	CbGpPWpGaD
Benazepril—SLC15A2—female reproductive system—urinary bladder cancer	0.0008	0.0222	CbGeAlD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000739	0.0345	CbGpPWpGaD
Benazepril—SLC15A2—vagina—urinary bladder cancer	0.000723	0.0201	CbGeAlD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.00072	0.0337	CbGpPWpGaD
Benazepril—MTHFR—One Carbon Metabolism—TYMS—urinary bladder cancer	0.000644	0.0301	CbGpPWpGaD
Benazepril—MTHFR—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00063	0.0295	CbGpPWpGaD
Benazepril—MTHFR—Trans-sulfuration and one carbon metabolism—TYMS—urinary bladder cancer	0.000579	0.0271	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000565	0.0264	CbGpPWpGaD
Benazepril—ACE—lymph node—urinary bladder cancer	0.000537	0.0149	CbGeAlD
Benazepril—MTHFR—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000525	0.0245	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—MPO—urinary bladder cancer	0.000512	0.024	CbGpPWpGaD
Benazepril—SLC15A2—lymph node—urinary bladder cancer	0.000468	0.013	CbGeAlD
Benazepril—MTHFR—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000407	0.019	CbGpPWpGaD
Benazepril—MTHFR—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000395	0.0185	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—SOD2—urinary bladder cancer	0.000322	0.015	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—GPX1—urinary bladder cancer	0.000307	0.0144	CbGpPWpGaD
Benazepril—SLC15A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000302	0.0141	CbGpPWpGaD
Benazepril—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00028	0.0131	CbGpPWpGaD
Benazepril—MTHFR—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000256	0.012	CbGpPWpGaD
Benazepril—MTHFR—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000244	0.0114	CbGpPWpGaD
Benazepril—ACE—Peptide hormone metabolism—IGF1—urinary bladder cancer	0.000217	0.0102	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000187	0.00876	CbGpPWpGaD
Benazepril—MTHFR—Folate Metabolism—IL2—urinary bladder cancer	0.000167	0.00783	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—CDX2—urinary bladder cancer	0.000155	0.00723	CbGpPWpGaD
Benazepril—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000155	0.00182	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000154	0.00182	CcSEcCtD
Benazepril—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000154	0.00181	CcSEcCtD
Benazepril—Chest pain—Etoposide—urinary bladder cancer	0.000153	0.00181	CcSEcCtD
Benazepril—Eosinophilia—Methotrexate—urinary bladder cancer	0.000153	0.00181	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000153	0.00717	CbGpPWpGaD
Benazepril—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000153	0.0018	CcSEcCtD
Benazepril—Insomnia—Fluorouracil—urinary bladder cancer	0.000153	0.0018	CcSEcCtD
Benazepril—Somnolence—Gemcitabine—urinary bladder cancer	0.000153	0.0018	CcSEcCtD
Benazepril—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000152	0.00179	CcSEcCtD
Benazepril—Pancreatitis—Methotrexate—urinary bladder cancer	0.000152	0.00179	CcSEcCtD
Benazepril—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000151	0.00178	CcSEcCtD
Benazepril—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000151	0.00178	CcSEcCtD
Benazepril—Somnolence—Fluorouracil—urinary bladder cancer	0.000151	0.00177	CcSEcCtD
Benazepril—Hypotension—Cisplatin—urinary bladder cancer	0.00015	0.00177	CcSEcCtD
Benazepril—MTHFR—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00015	0.00701	CbGpPWpGaD
Benazepril—Face oedema—Doxorubicin—urinary bladder cancer	0.00015	0.00176	CcSEcCtD
Benazepril—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000149	0.00176	CcSEcCtD
Benazepril—Fatigue—Gemcitabine—urinary bladder cancer	0.000148	0.00175	CcSEcCtD
Benazepril—Gastritis—Epirubicin—urinary bladder cancer	0.000148	0.00175	CcSEcCtD
Benazepril—Constipation—Gemcitabine—urinary bladder cancer	0.000147	0.00173	CcSEcCtD
Benazepril—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000147	0.00173	CcSEcCtD
Benazepril—Asthenia—Thiotepa—urinary bladder cancer	0.000147	0.00173	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000146	0.00172	CcSEcCtD
Benazepril—Infection—Etoposide—urinary bladder cancer	0.000146	0.00172	CcSEcCtD
Benazepril—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000145	0.00171	CcSEcCtD
Benazepril—Influenza—Epirubicin—urinary bladder cancer	0.000145	0.00171	CcSEcCtD
Benazepril—Asthma—Epirubicin—urinary bladder cancer	0.000145	0.00171	CcSEcCtD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000145	0.00677	CbGpPWpGaD
Benazepril—Neutropenia—Methotrexate—urinary bladder cancer	0.000145	0.00171	CcSEcCtD
Benazepril—Pruritus—Thiotepa—urinary bladder cancer	0.000145	0.00171	CcSEcCtD
Benazepril—Paraesthesia—Cisplatin—urinary bladder cancer	0.000144	0.0017	CcSEcCtD
Benazepril—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000144	0.0017	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000144	0.00671	CbGpPWpGaD
Benazepril—Eosinophilia—Epirubicin—urinary bladder cancer	0.000144	0.00169	CcSEcCtD
Benazepril—Dyspnoea—Cisplatin—urinary bladder cancer	0.000143	0.00169	CcSEcCtD
Benazepril—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000143	0.00168	CcSEcCtD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000142	0.00665	CbGpPWpGaD
Benazepril—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000142	0.00167	CcSEcCtD
Benazepril—Pancreatitis—Epirubicin—urinary bladder cancer	0.000142	0.00167	CcSEcCtD
Benazepril—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000142	0.00167	CcSEcCtD
Benazepril—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000141	0.00167	CcSEcCtD
Benazepril—Angina pectoris—Epirubicin—urinary bladder cancer	0.000141	0.00166	CcSEcCtD
Benazepril—Diarrhoea—Thiotepa—urinary bladder cancer	0.00014	0.00165	CcSEcCtD
Benazepril—Bronchitis—Epirubicin—urinary bladder cancer	0.000139	0.00164	CcSEcCtD
Benazepril—Hypotension—Etoposide—urinary bladder cancer	0.000137	0.00162	CcSEcCtD
Benazepril—Gastritis—Doxorubicin—urinary bladder cancer	0.000137	0.00162	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000137	0.00161	CcSEcCtD
Benazepril—Neutropenia—Epirubicin—urinary bladder cancer	0.000136	0.0016	CcSEcCtD
Benazepril—Dizziness—Thiotepa—urinary bladder cancer	0.000135	0.00159	CcSEcCtD
Benazepril—Influenza—Doxorubicin—urinary bladder cancer	0.000134	0.00158	CcSEcCtD
Benazepril—Asthma—Doxorubicin—urinary bladder cancer	0.000134	0.00158	CcSEcCtD
Benazepril—Pollakiuria—Epirubicin—urinary bladder cancer	0.000134	0.00158	CcSEcCtD
Benazepril—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000133	0.00156	CcSEcCtD
Benazepril—Sweating—Methotrexate—urinary bladder cancer	0.000132	0.00156	CcSEcCtD
Benazepril—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000132	0.00156	CcSEcCtD
Benazepril—Paraesthesia—Etoposide—urinary bladder cancer	0.000132	0.00156	CcSEcCtD
Benazepril—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000131	0.00155	CcSEcCtD
Benazepril—Dyspnoea—Etoposide—urinary bladder cancer	0.000131	0.00154	CcSEcCtD
Benazepril—Somnolence—Etoposide—urinary bladder cancer	0.000131	0.00154	CcSEcCtD
Benazepril—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000131	0.00154	CcSEcCtD
Benazepril—Vomiting—Thiotepa—urinary bladder cancer	0.00013	0.00153	CcSEcCtD
Benazepril—Rash—Thiotepa—urinary bladder cancer	0.000129	0.00152	CcSEcCtD
Benazepril—Bronchitis—Doxorubicin—urinary bladder cancer	0.000129	0.00152	CcSEcCtD
Benazepril—Dermatitis—Thiotepa—urinary bladder cancer	0.000129	0.00152	CcSEcCtD
Benazepril—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000129	0.00152	CcSEcCtD
Benazepril—Headache—Thiotepa—urinary bladder cancer	0.000128	0.00151	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000128	0.00151	CcSEcCtD
Benazepril—Fatigue—Etoposide—urinary bladder cancer	0.000127	0.00149	CcSEcCtD
Benazepril—Constipation—Etoposide—urinary bladder cancer	0.000126	0.00148	CcSEcCtD
Benazepril—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000126	0.00148	CcSEcCtD
Benazepril—Neutropenia—Doxorubicin—urinary bladder cancer	0.000125	0.00148	CcSEcCtD
Benazepril—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000125	0.00147	CcSEcCtD
Benazepril—Hepatitis—Methotrexate—urinary bladder cancer	0.000124	0.00146	CcSEcCtD
Benazepril—Sweating—Epirubicin—urinary bladder cancer	0.000124	0.00146	CcSEcCtD
Benazepril—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000124	0.00146	CcSEcCtD
Benazepril—Asthenia—Gemcitabine—urinary bladder cancer	0.000124	0.00146	CcSEcCtD
Benazepril—Pharyngitis—Methotrexate—urinary bladder cancer	0.000123	0.00145	CcSEcCtD
Benazepril—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000122	0.00144	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—TNF—urinary bladder cancer	0.000122	0.0057	CbGpPWpGaD
Benazepril—Pruritus—Gemcitabine—urinary bladder cancer	0.000122	0.00143	CcSEcCtD
Benazepril—Nausea—Thiotepa—urinary bladder cancer	0.000122	0.00143	CcSEcCtD
Benazepril—Sinusitis—Epirubicin—urinary bladder cancer	0.000121	0.00143	CcSEcCtD
Benazepril—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000121	0.00142	CcSEcCtD
Benazepril—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00012	0.00142	CcSEcCtD
Benazepril—Pruritus—Fluorouracil—urinary bladder cancer	0.00012	0.00141	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000119	0.0014	CcSEcCtD
Benazepril—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000118	0.00139	CcSEcCtD
Benazepril—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000118	0.00139	CcSEcCtD
Benazepril—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000117	0.00138	CcSEcCtD
Benazepril—Rhinitis—Epirubicin—urinary bladder cancer	0.000116	0.00137	CcSEcCtD
Benazepril—Abdominal pain—Etoposide—urinary bladder cancer	0.000116	0.00137	CcSEcCtD
Benazepril—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000116	0.00137	CcSEcCtD
Benazepril—Hepatitis—Epirubicin—urinary bladder cancer	0.000116	0.00137	CcSEcCtD
Benazepril—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000116	0.00136	CcSEcCtD
Benazepril—Tinnitus—Methotrexate—urinary bladder cancer	0.000116	0.00136	CcSEcCtD
Benazepril—Asthenia—Cisplatin—urinary bladder cancer	0.000115	0.00136	CcSEcCtD
Benazepril—Pharyngitis—Epirubicin—urinary bladder cancer	0.000115	0.00136	CcSEcCtD
Benazepril—Sweating—Doxorubicin—urinary bladder cancer	0.000115	0.00135	CcSEcCtD
Benazepril—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000114	0.00135	CcSEcCtD
Benazepril—MTHFR—Disease—GSTO2—urinary bladder cancer	0.000112	0.00526	CbGpPWpGaD
Benazepril—Sinusitis—Doxorubicin—urinary bladder cancer	0.000112	0.00132	CcSEcCtD
Benazepril—Dizziness—Fluorouracil—urinary bladder cancer	0.000112	0.00132	CcSEcCtD
Benazepril—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000112	0.00131	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000111	0.00518	CbGpPWpGaD
Benazepril—Diarrhoea—Cisplatin—urinary bladder cancer	0.00011	0.00129	CcSEcCtD
Benazepril—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00011	0.00129	CcSEcCtD
Benazepril—Alopecia—Methotrexate—urinary bladder cancer	0.00011	0.00129	CcSEcCtD
Benazepril—Vomiting—Gemcitabine—urinary bladder cancer	0.000109	0.00129	CcSEcCtD
Benazepril—Rash—Gemcitabine—urinary bladder cancer	0.000109	0.00128	CcSEcCtD
Benazepril—Dermatitis—Gemcitabine—urinary bladder cancer	0.000108	0.00128	CcSEcCtD
Benazepril—Hypersensitivity—Etoposide—urinary bladder cancer	0.000108	0.00128	CcSEcCtD
Benazepril—Tinnitus—Epirubicin—urinary bladder cancer	0.000108	0.00127	CcSEcCtD
Benazepril—Headache—Gemcitabine—urinary bladder cancer	0.000108	0.00127	CcSEcCtD
Benazepril—Flushing—Epirubicin—urinary bladder cancer	0.000108	0.00127	CcSEcCtD
Benazepril—Vomiting—Fluorouracil—urinary bladder cancer	0.000108	0.00127	CcSEcCtD
Benazepril—Rhinitis—Doxorubicin—urinary bladder cancer	0.000108	0.00127	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—TP53—urinary bladder cancer	0.000108	0.00503	CbGpPWpGaD
Benazepril—Hepatitis—Doxorubicin—urinary bladder cancer	0.000107	0.00126	CcSEcCtD
Benazepril—Rash—Fluorouracil—urinary bladder cancer	0.000107	0.00126	CcSEcCtD
Benazepril—Dermatitis—Fluorouracil—urinary bladder cancer	0.000107	0.00126	CcSEcCtD
Benazepril—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000107	0.00125	CcSEcCtD
Benazepril—Headache—Fluorouracil—urinary bladder cancer	0.000106	0.00125	CcSEcCtD
Benazepril—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000106	0.00125	CcSEcCtD
Benazepril—Asthenia—Etoposide—urinary bladder cancer	0.000105	0.00124	CcSEcCtD
Benazepril—Back pain—Methotrexate—urinary bladder cancer	0.000104	0.00123	CcSEcCtD
Benazepril—Pruritus—Etoposide—urinary bladder cancer	0.000104	0.00123	CcSEcCtD
Benazepril—Arrhythmia—Epirubicin—urinary bladder cancer	0.000104	0.00122	CcSEcCtD
Benazepril—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000103	0.00481	CbGpPWpGaD
Benazepril—Alopecia—Epirubicin—urinary bladder cancer	0.000103	0.00121	CcSEcCtD
Benazepril—Nausea—Gemcitabine—urinary bladder cancer	0.000102	0.0012	CcSEcCtD
Benazepril—Vomiting—Cisplatin—urinary bladder cancer	0.000102	0.0012	CcSEcCtD
Benazepril—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000101	0.0012	CcSEcCtD
Benazepril—Rash—Cisplatin—urinary bladder cancer	0.000101	0.00119	CcSEcCtD
Benazepril—Dermatitis—Cisplatin—urinary bladder cancer	0.000101	0.00119	CcSEcCtD
Benazepril—Diarrhoea—Etoposide—urinary bladder cancer	0.000101	0.00118	CcSEcCtD
Benazepril—Nausea—Fluorouracil—urinary bladder cancer	0.000101	0.00118	CcSEcCtD
Benazepril—Tinnitus—Doxorubicin—urinary bladder cancer	0.0001	0.00118	CcSEcCtD
Benazepril—Flushing—Doxorubicin—urinary bladder cancer	9.96e-05	0.00117	CcSEcCtD
Benazepril—Flatulence—Epirubicin—urinary bladder cancer	9.95e-05	0.00117	CcSEcCtD
Benazepril—MTHFR—Metabolism—GSTZ1—urinary bladder cancer	9.93e-05	0.00464	CbGpPWpGaD
Benazepril—Tension—Epirubicin—urinary bladder cancer	9.91e-05	0.00117	CcSEcCtD
Benazepril—Nervousness—Epirubicin—urinary bladder cancer	9.81e-05	0.00116	CcSEcCtD
Benazepril—Back pain—Epirubicin—urinary bladder cancer	9.77e-05	0.00115	CcSEcCtD
Benazepril—Dizziness—Etoposide—urinary bladder cancer	9.72e-05	0.00115	CcSEcCtD
Benazepril—ACE—Metabolism of proteins—IGFBP3—urinary bladder cancer	9.71e-05	0.00454	CbGpPWpGaD
Benazepril—Vertigo—Methotrexate—urinary bladder cancer	9.7e-05	0.00114	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.69e-05	0.00453	CbGpPWpGaD
Benazepril—Leukopenia—Methotrexate—urinary bladder cancer	9.66e-05	0.00114	CcSEcCtD
Benazepril—Arrhythmia—Doxorubicin—urinary bladder cancer	9.59e-05	0.00113	CcSEcCtD
Benazepril—Nausea—Cisplatin—urinary bladder cancer	9.53e-05	0.00112	CcSEcCtD
Benazepril—Alopecia—Doxorubicin—urinary bladder cancer	9.49e-05	0.00112	CcSEcCtD
Benazepril—Cough—Methotrexate—urinary bladder cancer	9.42e-05	0.00111	CcSEcCtD
Benazepril—MTHFR—Metabolism—NAT1—urinary bladder cancer	9.41e-05	0.0044	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTO2—urinary bladder cancer	9.41e-05	0.0044	CbGpPWpGaD
Benazepril—Vomiting—Etoposide—urinary bladder cancer	9.35e-05	0.0011	CcSEcCtD
Benazepril—Rash—Etoposide—urinary bladder cancer	9.27e-05	0.00109	CcSEcCtD
Benazepril—Dermatitis—Etoposide—urinary bladder cancer	9.26e-05	0.00109	CcSEcCtD
Benazepril—Headache—Etoposide—urinary bladder cancer	9.21e-05	0.00108	CcSEcCtD
Benazepril—Flatulence—Doxorubicin—urinary bladder cancer	9.21e-05	0.00108	CcSEcCtD
Benazepril—Arthralgia—Methotrexate—urinary bladder cancer	9.19e-05	0.00108	CcSEcCtD
Benazepril—Chest pain—Methotrexate—urinary bladder cancer	9.19e-05	0.00108	CcSEcCtD
Benazepril—Myalgia—Methotrexate—urinary bladder cancer	9.19e-05	0.00108	CcSEcCtD
Benazepril—Tension—Doxorubicin—urinary bladder cancer	9.17e-05	0.00108	CcSEcCtD
Benazepril—Nervousness—Doxorubicin—urinary bladder cancer	9.08e-05	0.00107	CcSEcCtD
Benazepril—Vertigo—Epirubicin—urinary bladder cancer	9.07e-05	0.00107	CcSEcCtD
Benazepril—Syncope—Epirubicin—urinary bladder cancer	9.06e-05	0.00107	CcSEcCtD
Benazepril—Leukopenia—Epirubicin—urinary bladder cancer	9.04e-05	0.00106	CcSEcCtD
Benazepril—Back pain—Doxorubicin—urinary bladder cancer	9.04e-05	0.00106	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.03e-05	0.00422	CbGpPWpGaD
Benazepril—Palpitations—Epirubicin—urinary bladder cancer	8.92e-05	0.00105	CcSEcCtD
Benazepril—Loss of consciousness—Epirubicin—urinary bladder cancer	8.88e-05	0.00105	CcSEcCtD
Benazepril—Cough—Epirubicin—urinary bladder cancer	8.81e-05	0.00104	CcSEcCtD
Benazepril—Anaphylactic shock—Methotrexate—urinary bladder cancer	8.81e-05	0.00104	CcSEcCtD
Benazepril—Infection—Methotrexate—urinary bladder cancer	8.75e-05	0.00103	CcSEcCtD
Benazepril—MTHFR—Disease—SLC19A1—urinary bladder cancer	8.74e-05	0.00409	CbGpPWpGaD
Benazepril—Nausea—Etoposide—urinary bladder cancer	8.73e-05	0.00103	CcSEcCtD
Benazepril—Thrombocytopenia—Methotrexate—urinary bladder cancer	8.62e-05	0.00102	CcSEcCtD
Benazepril—MTHFR—Metabolism—UGT2B7—urinary bladder cancer	8.61e-05	0.00403	CbGpPWpGaD
Benazepril—Arthralgia—Epirubicin—urinary bladder cancer	8.6e-05	0.00101	CcSEcCtD
Benazepril—Chest pain—Epirubicin—urinary bladder cancer	8.6e-05	0.00101	CcSEcCtD
Benazepril—Myalgia—Epirubicin—urinary bladder cancer	8.6e-05	0.00101	CcSEcCtD
Benazepril—Anxiety—Epirubicin—urinary bladder cancer	8.57e-05	0.00101	CcSEcCtD
Benazepril—MTHFR—Disease—PRSS3—urinary bladder cancer	8.52e-05	0.00398	CbGpPWpGaD
Benazepril—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.51e-05	0.001	CcSEcCtD
Benazepril—Vertigo—Doxorubicin—urinary bladder cancer	8.4e-05	0.000989	CcSEcCtD
Benazepril—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.38e-05	0.00392	CbGpPWpGaD
Benazepril—Syncope—Doxorubicin—urinary bladder cancer	8.38e-05	0.000987	CcSEcCtD
Benazepril—Leukopenia—Doxorubicin—urinary bladder cancer	8.36e-05	0.000985	CcSEcCtD
Benazepril—Palpitations—Doxorubicin—urinary bladder cancer	8.26e-05	0.000973	CcSEcCtD
Benazepril—Anaphylactic shock—Epirubicin—urinary bladder cancer	8.24e-05	0.000971	CcSEcCtD
Benazepril—Oedema—Epirubicin—urinary bladder cancer	8.24e-05	0.000971	CcSEcCtD
Benazepril—Hypotension—Methotrexate—urinary bladder cancer	8.23e-05	0.000969	CcSEcCtD
Benazepril—Loss of consciousness—Doxorubicin—urinary bladder cancer	8.21e-05	0.000967	CcSEcCtD
Benazepril—Infection—Epirubicin—urinary bladder cancer	8.19e-05	0.000964	CcSEcCtD
Benazepril—Cough—Doxorubicin—urinary bladder cancer	8.15e-05	0.00096	CcSEcCtD
Benazepril—MTHFR—Disease—HDAC4—urinary bladder cancer	8.13e-05	0.0038	CbGpPWpGaD
Benazepril—Shock—Epirubicin—urinary bladder cancer	8.11e-05	0.000955	CcSEcCtD
Benazepril—Thrombocytopenia—Epirubicin—urinary bladder cancer	8.07e-05	0.000951	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.02e-05	0.000945	CcSEcCtD
Benazepril—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.97e-05	0.000938	CcSEcCtD
Benazepril—Insomnia—Methotrexate—urinary bladder cancer	7.97e-05	0.000938	CcSEcCtD
Benazepril—Chest pain—Doxorubicin—urinary bladder cancer	7.96e-05	0.000937	CcSEcCtD
Benazepril—Myalgia—Doxorubicin—urinary bladder cancer	7.96e-05	0.000937	CcSEcCtD
Benazepril—Arthralgia—Doxorubicin—urinary bladder cancer	7.96e-05	0.000937	CcSEcCtD
Benazepril—Anxiety—Doxorubicin—urinary bladder cancer	7.93e-05	0.000934	CcSEcCtD
Benazepril—Paraesthesia—Methotrexate—urinary bladder cancer	7.91e-05	0.000931	CcSEcCtD
Benazepril—Dyspnoea—Methotrexate—urinary bladder cancer	7.85e-05	0.000925	CcSEcCtD
Benazepril—Somnolence—Methotrexate—urinary bladder cancer	7.83e-05	0.000922	CcSEcCtD
Benazepril—Dyspepsia—Methotrexate—urinary bladder cancer	7.75e-05	0.000913	CcSEcCtD
Benazepril—MTHFR—Metabolism—CYP4B1—urinary bladder cancer	7.75e-05	0.00363	CbGpPWpGaD
Benazepril—Hypotension—Epirubicin—urinary bladder cancer	7.7e-05	0.000907	CcSEcCtD
Benazepril—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.63e-05	0.000898	CcSEcCtD
Benazepril—Oedema—Doxorubicin—urinary bladder cancer	7.63e-05	0.000898	CcSEcCtD
Benazepril—Fatigue—Methotrexate—urinary bladder cancer	7.59e-05	0.000894	CcSEcCtD
Benazepril—Infection—Doxorubicin—urinary bladder cancer	7.58e-05	0.000892	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.51e-05	0.000884	CcSEcCtD
Benazepril—Shock—Doxorubicin—urinary bladder cancer	7.5e-05	0.000884	CcSEcCtD
Benazepril—Thrombocytopenia—Doxorubicin—urinary bladder cancer	7.47e-05	0.000879	CcSEcCtD
Benazepril—Insomnia—Epirubicin—urinary bladder cancer	7.45e-05	0.000878	CcSEcCtD
Benazepril—Paraesthesia—Epirubicin—urinary bladder cancer	7.4e-05	0.000872	CcSEcCtD
Benazepril—Hyperhidrosis—Doxorubicin—urinary bladder cancer	7.37e-05	0.000868	CcSEcCtD
Benazepril—Dyspnoea—Epirubicin—urinary bladder cancer	7.35e-05	0.000865	CcSEcCtD
Benazepril—Somnolence—Epirubicin—urinary bladder cancer	7.33e-05	0.000863	CcSEcCtD
Benazepril—MTHFR—Metabolism—SLC19A1—urinary bladder cancer	7.32e-05	0.00342	CbGpPWpGaD
Benazepril—Dyspepsia—Epirubicin—urinary bladder cancer	7.26e-05	0.000855	CcSEcCtD
Benazepril—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.2e-05	0.000848	CcSEcCtD
Benazepril—MTHFR—Metabolism—PRSS3—urinary bladder cancer	7.13e-05	0.00334	CbGpPWpGaD
Benazepril—Hypotension—Doxorubicin—urinary bladder cancer	7.13e-05	0.000839	CcSEcCtD
Benazepril—Fatigue—Epirubicin—urinary bladder cancer	7.11e-05	0.000837	CcSEcCtD
Benazepril—Constipation—Epirubicin—urinary bladder cancer	7.05e-05	0.00083	CcSEcCtD
Benazepril—Abdominal pain—Methotrexate—urinary bladder cancer	6.96e-05	0.00082	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.95e-05	0.000818	CcSEcCtD
Benazepril—Insomnia—Doxorubicin—urinary bladder cancer	6.9e-05	0.000812	CcSEcCtD
Benazepril—Paraesthesia—Doxorubicin—urinary bladder cancer	6.85e-05	0.000807	CcSEcCtD
Benazepril—Dyspnoea—Doxorubicin—urinary bladder cancer	6.8e-05	0.000801	CcSEcCtD
Benazepril—Somnolence—Doxorubicin—urinary bladder cancer	6.78e-05	0.000799	CcSEcCtD
Benazepril—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.74e-05	0.000794	CcSEcCtD
Benazepril—Dyspepsia—Doxorubicin—urinary bladder cancer	6.71e-05	0.000791	CcSEcCtD
Benazepril—Fatigue—Doxorubicin—urinary bladder cancer	6.57e-05	0.000774	CcSEcCtD
Benazepril—Constipation—Doxorubicin—urinary bladder cancer	6.52e-05	0.000768	CcSEcCtD
Benazepril—Abdominal pain—Epirubicin—urinary bladder cancer	6.52e-05	0.000767	CcSEcCtD
Benazepril—Hypersensitivity—Methotrexate—urinary bladder cancer	6.49e-05	0.000764	CcSEcCtD
Benazepril—MTHFR—Disease—LIG1—urinary bladder cancer	6.46e-05	0.00302	CbGpPWpGaD
Benazepril—Asthenia—Methotrexate—urinary bladder cancer	6.32e-05	0.000744	CcSEcCtD
Benazepril—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.24e-05	0.000735	CcSEcCtD
Benazepril—Pruritus—Methotrexate—urinary bladder cancer	6.23e-05	0.000734	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.1e-05	0.00285	CbGpPWpGaD
Benazepril—Hypersensitivity—Epirubicin—urinary bladder cancer	6.07e-05	0.000715	CcSEcCtD
Benazepril—Abdominal pain—Doxorubicin—urinary bladder cancer	6.03e-05	0.00071	CcSEcCtD
Benazepril—Diarrhoea—Methotrexate—urinary bladder cancer	6.03e-05	0.00071	CcSEcCtD
Benazepril—Asthenia—Epirubicin—urinary bladder cancer	5.91e-05	0.000697	CcSEcCtD
Benazepril—Pruritus—Epirubicin—urinary bladder cancer	5.83e-05	0.000687	CcSEcCtD
Benazepril—Dizziness—Methotrexate—urinary bladder cancer	5.82e-05	0.000686	CcSEcCtD
Benazepril—MTHFR—Metabolism—TYMP—urinary bladder cancer	5.7e-05	0.00267	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.66e-05	0.00265	CbGpPWpGaD
Benazepril—Diarrhoea—Epirubicin—urinary bladder cancer	5.64e-05	0.000664	CcSEcCtD
Benazepril—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.62e-05	0.000662	CcSEcCtD
Benazepril—Vomiting—Methotrexate—urinary bladder cancer	5.6e-05	0.00066	CcSEcCtD
Benazepril—Rash—Methotrexate—urinary bladder cancer	5.55e-05	0.000654	CcSEcCtD
Benazepril—Dermatitis—Methotrexate—urinary bladder cancer	5.55e-05	0.000653	CcSEcCtD
Benazepril—Headache—Methotrexate—urinary bladder cancer	5.52e-05	0.00065	CcSEcCtD
Benazepril—Asthenia—Doxorubicin—urinary bladder cancer	5.47e-05	0.000644	CcSEcCtD
Benazepril—Dizziness—Epirubicin—urinary bladder cancer	5.45e-05	0.000642	CcSEcCtD
Benazepril—Pruritus—Doxorubicin—urinary bladder cancer	5.4e-05	0.000636	CcSEcCtD
Benazepril—Vomiting—Epirubicin—urinary bladder cancer	5.24e-05	0.000617	CcSEcCtD
Benazepril—Nausea—Methotrexate—urinary bladder cancer	5.23e-05	0.000616	CcSEcCtD
Benazepril—Diarrhoea—Doxorubicin—urinary bladder cancer	5.22e-05	0.000615	CcSEcCtD
Benazepril—Rash—Epirubicin—urinary bladder cancer	5.2e-05	0.000612	CcSEcCtD
Benazepril—Dermatitis—Epirubicin—urinary bladder cancer	5.19e-05	0.000612	CcSEcCtD
Benazepril—Headache—Epirubicin—urinary bladder cancer	5.16e-05	0.000608	CcSEcCtD
Benazepril—MTHFR—Metabolism—NAT2—urinary bladder cancer	5.16e-05	0.00241	CbGpPWpGaD
Benazepril—Dizziness—Doxorubicin—urinary bladder cancer	5.04e-05	0.000594	CcSEcCtD
Benazepril—MTHFR—Disease—ENO2—urinary bladder cancer	4.92e-05	0.0023	CbGpPWpGaD
Benazepril—Nausea—Epirubicin—urinary bladder cancer	4.9e-05	0.000577	CcSEcCtD
Benazepril—Vomiting—Doxorubicin—urinary bladder cancer	4.85e-05	0.000571	CcSEcCtD
Benazepril—Rash—Doxorubicin—urinary bladder cancer	4.81e-05	0.000566	CcSEcCtD
Benazepril—Dermatitis—Doxorubicin—urinary bladder cancer	4.8e-05	0.000566	CcSEcCtD
Benazepril—Headache—Doxorubicin—urinary bladder cancer	4.78e-05	0.000563	CcSEcCtD
Benazepril—MTHFR—Disease—RBX1—urinary bladder cancer	4.67e-05	0.00218	CbGpPWpGaD
Benazepril—Nausea—Doxorubicin—urinary bladder cancer	4.53e-05	0.000534	CcSEcCtD
Benazepril—MTHFR—Metabolism—RRM2—urinary bladder cancer	4.45e-05	0.00208	CbGpPWpGaD
Benazepril—MTHFR—Disease—JAG1—urinary bladder cancer	4.18e-05	0.00195	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ENO2—urinary bladder cancer	4.12e-05	0.00193	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—HPGDS—urinary bladder cancer	4.12e-05	0.00193	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—IGF1—urinary bladder cancer	4.11e-05	0.00192	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTT1—urinary bladder cancer	4e-05	0.00187	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—NQO1—urinary bladder cancer	3.32e-05	0.00155	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—CXCL8—urinary bladder cancer	3.3e-05	0.00154	CbGpPWpGaD
Benazepril—MTHFR—Disease—NCOR1—urinary bladder cancer	3.04e-05	0.00142	CbGpPWpGaD
Benazepril—MTHFR—Disease—ERCC2—urinary bladder cancer	2.86e-05	0.00134	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.86e-05	0.00134	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTP1—urinary bladder cancer	2.77e-05	0.0013	CbGpPWpGaD
Benazepril—MTHFR—Disease—TERT—urinary bladder cancer	2.68e-05	0.00125	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.65e-05	0.00124	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—TYMS—urinary bladder cancer	2.58e-05	0.00121	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GSTM1—urinary bladder cancer	2.55e-05	0.00119	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—NCOR1—urinary bladder cancer	2.55e-05	0.00119	CbGpPWpGaD
Benazepril—MTHFR—Disease—FGFR3—urinary bladder cancer	2.46e-05	0.00115	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GPX1—urinary bladder cancer	2.44e-05	0.00114	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ERCC2—urinary bladder cancer	2.4e-05	0.00112	CbGpPWpGaD
Benazepril—MTHFR—Disease—CREBBP—urinary bladder cancer	2.09e-05	0.000979	CbGpPWpGaD
Benazepril—MTHFR—Disease—RHOA—urinary bladder cancer	1.89e-05	0.000886	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PPARG—urinary bladder cancer	1.83e-05	0.000854	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CREBBP—urinary bladder cancer	1.75e-05	0.00082	CbGpPWpGaD
Benazepril—MTHFR—Disease—ERBB2—urinary bladder cancer	1.75e-05	0.00082	CbGpPWpGaD
Benazepril—MTHFR—Disease—PTGS2—urinary bladder cancer	1.71e-05	0.000802	CbGpPWpGaD
Benazepril—MTHFR—Disease—CDKN1A—urinary bladder cancer	1.5e-05	0.000701	CbGpPWpGaD
Benazepril—MTHFR—Disease—PTEN—urinary bladder cancer	1.5e-05	0.000699	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTGS2—urinary bladder cancer	1.44e-05	0.000672	CbGpPWpGaD
Benazepril—MTHFR—Disease—EP300—urinary bladder cancer	1.43e-05	0.000667	CbGpPWpGaD
Benazepril—MTHFR—Disease—SRC—urinary bladder cancer	1.39e-05	0.000649	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTEN—urinary bladder cancer	1.25e-05	0.000586	CbGpPWpGaD
Benazepril—MTHFR—Disease—MYC—urinary bladder cancer	1.24e-05	0.000581	CbGpPWpGaD
Benazepril—MTHFR—Disease—EGFR—urinary bladder cancer	1.22e-05	0.000568	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—EP300—urinary bladder cancer	1.19e-05	0.000559	CbGpPWpGaD
Benazepril—MTHFR—Disease—KRAS—urinary bladder cancer	1.15e-05	0.000537	CbGpPWpGaD
Benazepril—MTHFR—Disease—HRAS—urinary bladder cancer	9.76e-06	0.000456	CbGpPWpGaD
